AN INTRODUCTION TO PET-CT SCANNING Ray Murphy Chair – MCCN Partnership Group.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Advanced breast cancer
CLINICAL USE OF SPECT-CT IN BREAST & PROSTATE CANCERS
Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Follow-up of GI Cancers Dr. Marianne Taylor BC Cancer Agency – CSI November 29, 2003.
Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.
Hong CM, Ahn BC, Jeong SY, Lee SW, Lee J
PET/CT in Oncology George Segall, M.D. Stanford University.
The Thyroid Incidentaloma
Large cell carcinoma Accounts for 5-10% of all lung cancers.
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
Merseyside and Cheshire Cancer Network HEPATO BILIARY MULTIDISCIPLINIARY TEAM MEETING Referral to Specialist HPB (Liver) MDT, University Hospital, Aintree,
Advances in Early Diagnosis and Treatment of Cancer July 17, 2007.
ENT Gerard Kelly and general practice The Leeds Teaching
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
Brain Scan Imaging MRI, CAT, PET Imaging Interpreting Functions of the Brain through Imaging – Activity Case Study – Professional Sports and Head Trauma.
Application of Positron Emission Tomography ( PET ) in Colorectal Cancer Dr Chan Wai Keung Department of Surgery Ruttonjee and Tang Shiu Kin Hospitals.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Cancer Card Game Answers etc.
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
Radiotherapy for Kidney cancer
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
Acute Oncology Service (AOS) Monday – Friday 8am – 4pm Bleep: 946 T: x5726 F: Dr Nicola Beech Dr Jillian Noble Dr Susannah.
Medical Imaging Technology
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
TUMOURS OF NASAL CAVITY & PARANASAL SINUSES
Teenagers and Young Adults with Cancer Chemotherapy Conference 19 th March 2009 Linda Devereux Associate Director.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99 mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT,
Dual-time point 18F-FDG PET/CT scan: is it always working?
Positron Emission Tomography (PET)
M. Wissmeyer Department of Nuclear Medicine, University of Berne (Inselspital) PET/CT in Radiation Oncology: Current Evidence and Future Perspectives.
PET Applications in Oncology
Dr Jagrit Shah Consultant Neuroradiologist & Head and Neck Radiologist Nottingham University Hospitals NHS Trust.
Resection For Lung Metastases M62 Coloproctology Course.
PET-CT in Scotland Dr Fergus McKiddie John Mallard PET Centre Aberdeen Royal Infirmary.
WHAT ARE THE RISK FACTORS FOR LUNG CANCER? SMOKING.
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.
Potentially curative re-resection of recurrent CRC  Suture line recurrences  Isolated liver metastases  Isolated pulmonary metastases.
STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma.
Syrian private University Medical Faculty Department of Surgery Principles of cancer surgery M.A.Kubtan, MD-FRCS.
Stereotactic Ablative Body Radiotherapy for Non small cell lung cancer
Introduction to NM Omima Adam NMT 231. What is nuclear medicine NM Is the branch of medicine that uses radiation and nuclear properties of radionuclide's.
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Differential diagnosis of head and neck swellings
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnostic Accuracy of Colorectal Cancer Staging.
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.
A prospective study of PET/CT in initial staging of small-cell lung cancer : comparison with CT, bone scintigraphy and bone marrow analysis B. M. Fischer1,
FDG Squamous Cell Carcinoma of Tonsil
Brain imaging prior to lung cancer resection
Melanoma Staging an update
PET Applications in Oncology 2015/2016
Primitive Ano-rectal area melanoma:Case Report
1 Maidstone and Tunbridge Wells NHS Trust (Kent Oncology Centre)
CUP SSG May 2016 Dr Matt sephton
SWAG Cancer Alliance Update
Medical Imaging Technologies
Positron emission tomography (PET scan)
Pathway for patients with suspected HPB Cancer Inter Provider Transfer
(A) Na18F PET images (maximum-intensity projection).
Serial CT scan images from patient with a partial response.
Presentation transcript:

AN INTRODUCTION TO PET-CT SCANNING Ray Murphy Chair – MCCN Partnership Group

PET-CT Scanning A PET-CT scan is a diagnostic imaging tool used in the investigation of cancers It is a two fold process by which the anatomic detail of the CT scan (Computerised Tomography) is combined with the glucose uptake detection of the PET scan (Positron Emission Tomography). This give a very accurate determination of the disease and identifies small metastases that would be undetected by CT alone

PET-CT Use Cancer diagnosis and treatment planning are the main uses for PET-CT, which may : Identify cancer earlier than other imaging technologies Distinguish between malignant and benign tumours Determine the location and extent of cancer indicating spread to other areas of the body such as lymph nodes, liver or bones (metastatic disease) Identify recurrent cancer distinguishing it from scar tissue or fibrosis Demonstrate the response of cancer to treatment

PET-CT Scan

Lung Tumour

Metastatic Spread

Response to Treatment

Merseyside and Cheshire PET-CT Service The Merseyside and Cheshire PCTs are part of the Department of Health’s national contract for the provision of PET-CT services We are now in year 3 of a 5 year contract in which Alliance Medical are the providers of a mobile PET-CT service The mobile units visit two sites, Broadgreen in the north and Clatterbridge in the south The planned number of scans is in the order of 2000 per year in this Network

Current Criteria All lung cancer patients suitable for radical surgery or radiotherapy. Also for patients post radical therapy with suspected disease relapse when detection of recurrence would affect management All lymphoma patients All patients with anal cancer suitable for radical radiotherapy Patients with colorectal cancer who are considered for radical treatment with a prior history of colorectal cancer and proven or suspected disease relapse, and patients with synchronous metastases at presentation potentially suitable for resection Oesophageal cancers

Current Criteria (cntd…) Some head and neck, melanoma and brain tumours All patients with gastro intestinal tumours unsuitable for complete surgical resection In patients with locally extensive uterine carcinoma (cervix/endometrium) which is potentially curable by exenterative surgery In patients with intrahepatic cholangiocarcinoma or gallbladder carcinoma which is potentially curable by radical surgery Patients with suspected tumour relapse not confirmed on conventional scanning, when detection would alter therapy and outcome

The UK PET-CT Advisory Board have recently made their recommendations Estimated number of cases for England Lung cancer 10,000 12,500 Lymphoma 15,000 20,500 Colorectal 5,000 3,125 Anal - 75 Oesophageal 2,000 3,500 GIST Melanoma - 1,500 Paraneoplastic syndromes - 75 Brain/spinal Head & neck 3,000 1,500 Suspected relapse unconfirmed on conventional scanning - 3,000 Cervix/endometrium Cholagiocarcinoma/gall-bladder Contingency studies (15%) - 5,000 Total 35,000 52,550 Number per million population 800 1,000

Alliance Medical Service Operates from mobile units at both Clatterbridge and Broadgreen Has a requirement to scan a patient within 5 days of their referral Uses several local NHS radiologists reporting the finding of the scans Has a requirement to return the images and the reports to the referring clinician within 2 days of the scan

Activity Levels In the first year of the contract the level of activity performed was far lower than the levels contracted for, mainly due to a lack in clinical confidence in the service following an initial reporting problem and the time take for the reports to be returned to the MDTs This year the activity levels have risen far closer to the planned levels More patients are scanned at Broadgreen that Clatterbridge but work is underway to balance this out

The number of scans performed on the Broadgreen site

The number of scans performed on the Clatterbridge site

The percentage of reported returned to the referring Trust within 2 days

Patient Satisfaction

Mobile PET-CT Scanners

Service Issues One of the local residents adjacent to the Broadgreen site has been throwing fruit and vegetables at the scanner. This is in protest to the noise and timing of the scanner movements. The Trust and AML have agreed a compromise with the individual and the problem seems to be resolved.